Good News | Hillgene Won the Title of “Star of Tomorrow” among the China Biopharmaceutical CDMO Companies in Star Awards-2021 BPID

On October 11-12, 2021, the BPID Biopharmaceutical Industry Development Conference and the 2021 Life and Health Industry Summit Forum were successfully concluded in Shanghai. The conference discussed hot topics such as local biopharmaceutical innovation, artificial intelligence and smart healthcare, investment strategies for innovative biopharmaceuticals, cutting-edge technologies for innovative biopharmaceuticals, biopharmaceutical CDMO production processes, and preclinical research and registration applications for biopharmaceuticals. At the 2021 Star Awards Ceremony held at the same time, Spectrum Biotech successfully won the title of "China's Biopharmaceutical CDMO Enterprise of Tomorrow".

Xu Xianbin (center position), Vice President of Operations of Spectrum Biotech, went on stage to receive the award

“Rising Star” is a reflection of the current situation of Spectrum Biotech. This award shows that the company has made its mark in the industry. At the same time, the company will continue to demonstrate its expertise and potential.